HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A de-novo deletion of dystrophin provoking severe 'peri-partum cardiomyopathy': The importance of genetic testing in peripartum cardiomyopathy to uncover female carriers.

AuthorsAyesha Ahmed, Stefan Spinty, Victoria Murday, Cheryl Longman, Aleem Khand
JournalInternational journal of cardiology (Int J Cardiol) Vol. 203 Pg. 1084-5 (Jan 15 2016) ISSN: 1874-1754 [Electronic] Netherlands
PMID26651149 (Publication Type: Case Reports, Letter)
Chemical References
  • Dystrophin
Topics
  • Adult
  • Cardiomyopathies (diagnostic imaging, genetics)
  • Dystrophin (deficiency, genetics)
  • Echocardiography
  • Female
  • Genetic Carrier Screening (methods)
  • Genetic Testing (methods)
  • Humans
  • Infant, Newborn
  • Male
  • Peripartum Period
  • Pregnancy
  • Puerperal Disorders (genetics)
  • Sequence Deletion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: